Monitoring of dimethyl sulphate-induced N3-methyladenine, N7-methylguanine and O6-methylguanine DNA adducts using reversed-phase high performance liquid chromatography and mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 867, Issue 1, 2008, Pages 43-48

  Chadt, Jiri ^a,b   Sykora, David ^c   Nilsson, Robert ^d   Vodicka, Pavel ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^d NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Dimethyl sulphate; DNA methylated adducts; HPLC; LC MS ESI(+); N3 methyladenine; N7 methylguanine; O6 methylguanine

Indexed keywords

ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

DIMETHYL SULPHATE; LIMIT OF DETECTION; METHYLATED DNA ADDUCTS; N3-METHYLADENINE; N7-METHYLGUANINE;

DNA;

3 METHYLADENINE; 6 O METHYLGUANINE; 7 METHYLGUANINE; DIMETHYL SULFATE; DNA;

ACCURACY; ARTICLE; CALIBRATION; DNA ADDUCT; ELECTROSPRAY MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION;

ADENINE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; DNA ADDUCTS; GUANINE; MALE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SULFURIC ACID ESTERS; TESTIS;

EID: 42749084161     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.03.008     Document Type: Article

References (45)

1. Farmer P.B. Toxicol. Lett. 149 (2004) 3
2. Cloutier J.F., Castonguay A., O'Connor T.R., and Drouin R. J. Mol. Biol. 306 (2001) 169
3. Guichard Y., Jones G.D.D., and Farmer P.B. Cancer Res. 60 (2000) 1276
4. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Dimethyl Sulfate, vol. 71 (1999), IARC, Lyon p. 575
5. Hoffmann G.R., Crowley D.J., and Theophiles P.J. Mutagenesis 17 (2002) 439
6. Shuker D.E. IARC Sci. Publ. 89 (1988) 296
7. Shuker D.E., and Bartsch H. Mutat. Res. 313 (1994) 263
8. Jain R., and Sharma M. Cancer Res. 53 (1993) 2771
9. Bianchini F., Montesano R., Shuker D.E., Cuzick J., and Wild C.P. Carcinogenesis 14 (1993) 1677
10. Kaur H., and Halliwell B. Biochem. J. 318 (1996) 21
11. Chao M.R., Wang C.J., Chang L.W., and Hu C.W. Carcinogenesis 27 (2006) 146
12. Barak R., Vincze A., Bel P., Dutta S.P., and Chedda G.B. Chem. Biol. Interact. 86 (1993) 29
13. Hua Y., Wainhaus S.B., Yang Y., Shen L., Xiong Y., Xu X., Zhang F., Bolton J.L., and van Breemen R.B. J. Am. Soc. Mass Spectrom. 12 (2001) 80
14. Mustonen R., Schoket B., and Hemminki K. Carcinogenesis 14 (1993) 151
15. Mustonen R., and Hemminki K. Carcinogenesis 13 (1992) 1951
16. Kumar R., Vodicka P., Koivisto P., Peltonen K., and Hemminki K. Carcinogenesis 17 (1996) 1297
17. Kumar R., Vodicka P., Peltonen K., and Hemminki K. Carcinogenesis 18 (1997) 407
18. Yang K., Fang J.L., Li D., Chung F.L., and Hemminki K. IARC Sci. Publ. 150 (1999) 205
19. Kim D.Y., Cho M.H., Yang H.K., Hemminki K., Kim J.P., Jang J.J., and Kumar R. Jpn. J. Cancer Res. 90 (1999) 1104
20. Haque K., Cooper D.P., and Povey A.C. Carcinogenesis 15 (1994) 2485
21. Vodicka P., and Hemminki K. IARC Sci. Publ. 127 (1993) 109
22. Vodicka P., Vodickova L., and Hemminki K. Carcinogenesis 14 (1993) 2059
23. Vodicka P., Stetina R., Kumar R., Plna K., and Hemminki K. Carcinogenesis 17 (1996) 801
24. Zhao C., Tyndyk M., Eide I., and Hemminki K. Mutat. Res. 424 (1999) 117
25. Vodicka P., and Hemminki K. Chem. Biol. Interact. 68 (1988) 117
26. Hemminki K., Peltonen K., and Vodicka P. Chem. Biol. Interact. 70 (1989) 289
27. Gates K.S., Nooner T., and Dutta S. Chem. Res. Toxicol. 17 (2004) 840
28. Deutsch W.A., and Hegde V. Methods Mol. Biol. 314 (2006) 355
29. Li Q., Laval J., and Ludlum D.B. Carcinogenesis 18 (1997) 1035
30. Bianchini F., and Wild C.P. Cancer Lett. 87 (1994) 131
31. Kyrtopoulos S.A., Anderson L.M., Chhabra S.K., Souliotis V.L., Pletsa V., Valavanis C., and Georgiadis P. Cancer Detect. Prev. 21 (1997) 391
32. Christmann M., Tomicic M.T., Roos W.P., and Kaina B. Toxicology 193 (2003) 3
33. Fronza G., and Gold B. J. Cell. Biochem. 91 (2004) 250
34. Souliotis V.L., Sfikakis P.P., Anderson L.M., and Kyrtopoulos S.A. Mutat. Res. 568 (2004) 155
35. Levati L., Marra G., Lettieri T., D'Atri S., Vernole P., Tentori L., Lacal P.M., Pagani E., Bonmassar E., Jiricny J., and Graziani G. Genes Chromosomes Cancer 23 (1998) 159
36. Middleton M.R., Lee S.M., Arance A., Wood M., Thatcher N., and Margison G.P. Int. J. Cancer 88 (2000) 469
37. NIH. Guidelines for the Laboratory Use of Chemical Carcinogen (1990), U.S. Government Printing Office, Washington, DC
38. Koskinen M., Calebiro D., and Hemminki K. Chem. Biol. Interact. 126 (2000) 201
39. Catinella S., Rovatti L., Hamdan M., Porcelli B., Frosi B., and Marinello E. Rapid Commun. Mass Spectrom. 11 (1997) 869
40. Zhang F., Bartels M.J., Pottenger L.H., Gollapudi B.B., and Schisler M.R. J. Chromatogr. B 833 (2006) 141
41. Ross M.K., Said B., and Shank R.C. Toxicol. Sci. 53 (2000) 224
42. Wurdeman R.L., Douskey M.C., and Gold B. Nucleic Acids Res. 21 (1993) 4975
43. Kopplin A., Eberle-Adamkiewicz G., Glusenkamp K.H., Nehls P., and Kirstein U. Carcinogenesis 1995 (1995) 2637
44. Engelward B.P., Allan J.M., Dreslin A.J., Kelly J.D., Wu M.M., Gold B., and Samson L.D. J. Biol. Chem. 273 (1998) 5412
45. Szyfter K., Hemminki K., Szyfter W., Szmeja Z., Banaszewski J., and Pabiszczak M. Carcinogenesis 17 (1996) 501